A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL

Clinical trial NCT04412174 · UNKNOWN

Trial details

NCT number: NCT04412174
Sponsor: Hebei Yanda Ludaopei Hospital
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

B-cell Non Hodgkin Lymphoma

Start date: 2020-06-01
Primary completion: 2022-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.